Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

The rabbit model found that the levels of the active metabolites were very comparable, whether or not eyes had received a prior installation of perfluorohexyloctane.

The study evaluated the effects of long-term, low-dose aspirin administration in over 3000 older adults.

North Bay Eye Associates transitions from traditional bowl perimeter to portable vision diagnostic and patient engagement system.

Conjunctivitis was the only symptom identified in the second reported case.

Real-world insights can clear the path to trends and strategies to meet patients’ needs.

Catch up on what happened in optometry during the week of May 20-May 24.

The Tono-Vera Tonometer allows for automated IOP measurements and eliminates the need for a topical anesthetic.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Christina Schiller, OD, Blake Jarrard, OD, and Christopher Herring, OD, were this year’s recipients.

Reed, OD, will take on the acting president role for the next two months and will be instated as president during this year's Optometry's Meeting.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

Aflibercept-jbvf and aflibercept-yszy are the first interchangeable biosimilars to aflibercept 2 mg that have been approved in the US.

Providing prevention strategies can keep patients comfortable during allergy season.

South Dakota’s newest scope expansion bill, signed into law earlier this year, offers new opportunities for optometrists.